Genomic Health (NASDAQ: GHDX) reported Q3 EPS of ($0.20), $0.02 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $69.1 million versus the consensus estimate of $71 million.

For earnings history and earnings-related data on Genomic Health (GHDX) click here.